Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05787821

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study A Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation

Status
Recruiting
Phase
Study type
Observational
Enrollment
760 (estimated)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

Detailed description

The study design is a prospective, multicenter data collection model of the 510(k) cleared Persona Total Knee System. The study will require each site to obtain institutional review board (IRB) approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process. All study subjects will undergo preoperative clinical evaluations prior to their total knee arthroplasty (TKA). Investigators will collect clinical data for a required 5 years. Follow-up clinical visits include 3 months, 1, 2, 5, 7 and 10 years post-operatively. Specific assessments include: 1. Confirming the safety, performance and clinical benefits of the Persona total knee system and instrumentation in primary and revision TKA. 2. Verifying that, under normal use, the performance and clinical benefits of this device and its instrumentation conform to those intended by the manufacturer by recording patient-reported clinical outcomes measures (PROMs) and radiographic outcomes (if available).

Conditions

Interventions

TypeNameDescription
DEVICETotal Knee ArthroplastyTotal knee replacement.

Timeline

Start date
2023-06-28
Primary completion
2026-06-01
Completion
2035-06-01
First posted
2023-03-28
Last updated
2026-01-20

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05787821. Inclusion in this directory is not an endorsement.